Back to News
Market Impact: 0.25
Repligen Corp Completes Acquisition Of BioLife Solutions
Source: Nasdaq
M&A & RestructuringHealthcare & Biotech
Repligen completed its previously announced acquisition of BioLife Solutions, a supplier of cell-processing tools and services for the cell and gene therapy market. The article provides no transaction value or other financial terms.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
BLFS0.10
RGEN0.40
More News
- Former world No. 1 Jon Rahm's lawyer tells court Spaniard is done with LIV Golf after three seasons
- Weston Family, Fairfax Financial’s Watsa Acquire Boots in $8.9 Billion Deal
- Why Paramount-Warner merger has sparked fears about press freedom
- Profound Medical stock surges 20% on raised Q3 revenue outlook
- This unique energy stock is a dual threat, offering both income and growth
- Intermap completes PCI Geomatics acquisition for $7.7 million